期刊文献+

依维莫司的合成 被引量:4

Synthesis of Everolimus
原文传递
导出
摘要 乙二醇依次与叔丁基二苯基氯硅烷、对甲基苯磺酰氯、溴化钠反应生成(2-溴乙氧基)叔丁基二苯基硅烷,再与西罗莫司、三氟甲磺酸银反应生成40-O-(2-叔丁基二苯基硅氧基乙基)雷帕霉素,再水解生成依维莫司,总收率约43%。 Ethylene glycol was reacted with tert-butylchlorodiphenylsilane, tosyl chloride and sodium bromide to give (2-bromoethoxy) (tert-butyl) diphenylsilane, which was coupled with sirolimus in the presence of silver trifluorom ethanesulfonate to give 40-0- [2- (tert-butyldiphenylsilyloxy) ethyl] rapamycin, followed by hydrolysis with hydrofluoric acid to provide everolimus with an overall yield about 43 %.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2016年第1期1-3,共3页 Chinese Journal of Pharmaceuticals
关键词 依维莫司 大环内酯类化合物 抗肿瘤药 三氟甲磺酸银 合成 everolimus macrolides compound antitumor drug silver trifluoromethanesulfonate synthesis
  • 相关文献

参考文献8

  • 1王峰,虞小平,殷侃,等.依维莫司的制备工艺:中国,103848849 [P]. 2014-06-11. 被引量:1
  • 2Cottens S, Sedrani R. Oalkylated rapamycin derivativesand their use, particularly as immunosuppersstants: WO,94009010 [P]. 1994-04-28. 被引量:1
  • 3Kayo MW, Fornicola, RS, Kovacik I. Low temperaturesynthesis of rapamycin derivatives: WO, 2014116611 [P].2014-07-31. 被引量:1
  • 4杨智亮,王国平,侯建.一种依维莫司的制备方法:CN,102786534A[P].2012-11-21. 被引量:4
  • 5Venkata SP, Ekambaram G, Kothakonda KK, et al. Processesfor preparation of everolimus and intermediates thereof: WO,2012066502 [P]. 2012-05-24. 被引量:1
  • 6蔡泽贵.一种依维莫司的合成方法:CN102268015[P].2011-12-07. 被引量:4
  • 7苟少华,诸海滨.依维莫斯的制备:中国,102127092A[P].2011-07-20. 被引量:2
  • 8Luten J, Keltjens R, Benes M, et al. Process for makingeverolimus: WO, 2012103959 [P]. 2012-08-09. 被引量:1

共引文献4

同被引文献16

  • 1陈烨,郑颖,徐利锋.依维莫司抗肾细胞癌研究进展[J].辽宁大学学报(自然科学版),2011,38(1):60-66. 被引量:4
  • 2蔡泽贵.一种依维莫司的合成方法:CN102268015[P].2011-12-07. 被引量:4
  • 3杨智亮,王国平,侯建.一种依维莫司的制备方法:CN,102786534A[P].2012-11-21. 被引量:4
  • 4Venkata SP, Ekambaram G, Kothakonda KK, et al. Processes for preparation of everolimus and intermediates thereof: WO, 2012066502 EP]. 2012-05-24. 被引量:1
  • 5Cottens S, Sedrani R. O-Alkyated rapamycin derivatives and their use, particularly as immunosuppressants: WO, 9409010 [P]. 1994-04-28. 被引量:1
  • 6Luten J, Keltfens R, Benes M, et al. Process for making everolimus: WO, 2012/103959A1 [P]. 2012,08-08. 被引量:1
  • 7Venkata SP, Ekambaram G, Kothakonda KK, et al. Processes for preparation of everolimus and intermediates thereof: WO, 2012066502 EP]. 2012-05-24. 被引量:1
  • 8Cottens S, Sedrani R. O-Alkyated rapamycin derivatives and their use, particularly as immunosuppressants: WO, 9409010 [P]. 1994-04-28. 被引量:1
  • 9Luten J, Keltfens R, Benes M, et al. Process for making everolimus: WO, 2012/103959A1 [P]. 2012,08-08. 被引量:1
  • 10张梦莎,孙铁民.依维莫司(everolimus)[J].中国药物化学杂志,2010,20(6):553-554. 被引量:2

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部